Shade Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 14
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.23M
Latest Deal Amount
  • Investors
  • 13

Shade General Information


Developer of a wearable UV sensor designed to offer real-time and accurate measurements of UV exposure with a scientific approach centered on clinical evidence and peer-reviewed publications. The company's sensor determines the daily threshold of UV exposure for care in dermatology for photosensitive diseases like skin cancer and other autoimmune diseases, thus providing autoimmune disease patients with timely notifications so that they can make decisions about when to get inside and when to enjoy the sunshine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Therapeutic Devices
Primary Office
  • 215 West 125th Street
  • 4th Floor
  • New York, NY 10027
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shade Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC $2.23M 00.000 Completed Generating Revenue
6. Grant 01-Jan-2020 00000 00000 Completed Generating Revenue
5. Grant 19-Jan-2017 00.00 00000 Completed Generating Revenue
4. Accelerator/Incubator 17-Feb-2015 0000 00000 Completed Generating Revenue
3. Accelerator/Incubator 15-Jun-2014 00000 00000 Completed Generating Revenue
2. Early Stage VC 01-Mar-2014 $100K $250K Completed Generating Revenue
1. Accelerator/Incubator 10-Feb-2014 $150K $150K Completed Generating Revenue
To view Shade’s complete valuation and funding history, request access »

Shade Executive Team (4)

Name Title Board Seat Contact Info
Emmanuel Dumont Ph.D Co-Founder & Chief Executive Officer
Peter Kaplan Ph.D Chief Technology Officer
Geoff Appelboom MD Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

Shade Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shade Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Highway1 Accelerator/Incubator 000 0000 000000 0
Weill Cornell Medical College Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »